← All organizations

Celsion

For profitWebsite ↗

Also known as: Celsion | Celsus Therapeutics PLC | Imunon

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 9, 2025

Timeline

2000s

May 1, 2000
Celsion— Founded

2010s

Jun 10, 2014
EGEN, Inc.— Acquired

Drugs by trial phase (13 distinct, 19 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (5 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

EGEN, Inc.

Recent trials (21)

NCT06915025Lead sponsorPhase 3Jul 9, 2025
NCT06283459Lead sponsorPhase 1/Phase 2Jun 4, 2024
NCT06283459OfficialPhase 1/Phase 2Jun 4, 2024
NCT05739981Lead sponsorPhase 1/Phase 2Feb 10, 2023
NCT04852367CollaboratorPhase 1Jun 16, 2021
NCT03393884Lead sponsorPhase 1/Phase 2Sep 5, 2018
NCT02850419Lead sponsorPhase 2Aug 1, 2017
NCT02480374Lead sponsorPhase 1Sep 1, 2015
NCT02031445Lead sponsorPhase 2Aug 1, 2014
NCT02181075CollaboratorPhase 1Jul 1, 2014
NCT02112656Lead sponsorPhase 3Jun 1, 2014
NCT00826085Lead sponsorPhase 1/Phase 2Feb 1, 2013
NCT00826085Study directorPhase 1/Phase 2Feb 1, 2013
NCT01464593Lead sponsorPhase 2Sep 1, 2011
NCT01464593Study directorPhase 2Sep 1, 2011

Details

Founded: Lawrenceville, NJ, US May 1, 2000
Last known activity: Jul 9, 2025